Moleculin Biotech
MBRX
MBRX
11 hedge funds and large institutions have $213K invested in Moleculin Biotech in 2016 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
11
Holders Change
+2
Holders Change %
+22.22%
% of All Funds
0.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
1
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Bank of America
Charlotte,
North Carolina
| $57K | +$57K | +278 | New |
|
2
Truist Financial
Charlotte,
North Carolina
| $46K | +$46K | +222 | New |
|
|
BFA
3
BlackRock Fund Advisors
San Francisco,
California
| $41K | +$41K | +199 | New |
|
4
Vanguard Group
Malvern,
Pennsylvania
| $41K | +$41K | +200 | New |
|
5
Citigroup
New York
| $17K | +$5.53K | +27 | +48% |
|
6
UBS Group
Zurich,
Switzerland
| $5K | -$833 | -4 | -14% |
|
7
Morgan Stanley
New York
| $2K | – | – | – |
|
|
AWMS
8
Advocacy Wealth Management Services
Atlanta,
Georgia
| $2K | +$2K | +11 | New |
|
|
WA
9
WFG Advisors
Dallas,
Texas
| $1K | – | – | – |
|
|
NFG
10
Next Financial Group
Houston,
Texas
| $1K | – | – | – |
|
|
IG
11
ING Group
Amsterdam,
Netherlands
| – | -$122K | -222 | Closed |
|
|
VKH
12
Virtu KCG Holdings
New York
| – | -$66K | -129 | Closed |
|
|
AIM
13
Acrospire Investment Management
Chicago,
Illinois
| – | -$9K | -18 | Closed |
|